[Guidelines for the management of Crohn's disease]
Byong Duk Ye1, Suk-Kyun Yang, Sung Jae Shin
1Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.
Insights
This study introduces the first Korean guidelines for managing Crohn's disease (CD), a chronic inflammatory bowel disease (IBD). These guidelines aim to standardize treatment approaches for various CD complications and patient scenarios in Korea.
Area of Science:
- Gastroenterology
- Internal Medicine
- Clinical Practice Guidelines
Background:
- Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) with increasing incidence in Korea.
- Current CD management often relies on physician experience, leading to variability in care.
- Serious complications of CD include strictures, perforations, and fistulas.
Purpose of the Study:
- To develop the first Korean guidelines for the management of Crohn's disease (CD).
- To provide standardized approaches for diverse CD clinical situations and complications.
- To minimize variations in CD management decisions among physicians.
Main Methods:
- Adaptation methods were used to develop the guidelines.
- Guidelines cover treatment of inflammatory, stricturing, and penetrating CD.
- Recommendations include surgical indications, post-operative recurrence prevention, and management during pregnancy/lactation.
Main Results:
- The guidelines provide a comprehensive framework for CD management in Korea.
- They address various disease manifestations, including inflammation, strictures, and penetrating disease.
- Specific recommendations are provided for surgical interventions and special patient populations.
Conclusions:
- These represent the first Korean guidelines for Crohn's disease management.
- The guidelines aim to standardize care and improve outcomes for IBD patients in Korea.
- Future updates incorporating new scientific evidence are necessary.
Abstract:
Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) with uncertain etiopathogenesis. CD can involve any site of gastrointestinal tract from the mouth to anus and is associated with serious complications such as bowel strictures, perforations, and fistula formation. The incidence and prevalence rates of CD in Korea are still lower than those of Western countries, but have been rapidly increasing during the past decades. Although there are no definitive curative modalities for CD, various medical and surgical therapies are currently applied for diverse clinical situations of CD. However, a lot of decisions on the management of CD are made depending on the personal experiences and choices of physicians. To suggest preferable approaches to diverse problems of CD and to minimize the variations according to physicians, guidelines for the management of CD are needed. Therefore, IBD Study Group of the Korean Association for the Study of the Intestinal Diseases has set out to develop the guidelines for the management of CD in Korea. These guidelines were developed using the adaptation methods and encompass the treatment of inflammatory disease, stricturing disease, and penetrating disease. The guidelines also cover the indication of surgery, prevention of recurrence after surgery, and CD in pregnancy and lactation. These are the first Korean guidelines for the management of CD and the update with further scientific data and evidences is needed.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...


